lamivudine has been researched along with Atrophy in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azu, OO; Chuturgoon, A; Masia, T; Naidu, EC; Naidu, JS; Nzemande, NF; Singh, S | 1 |
| Capeau, J; Danner, SA; Domingo, P; Feeney, ER; Mallon, PW; Reiss, P; van Agtmael, MA; van Vonderen, MG; Villarroya, F; Wit, F | 1 |
| Arribas, JR; Arrizabalaga, J; Bernardino, JI; Domingo, P; Martinez, E; Muñoz, J; Ocampo, A; Portilla, J; Pulido, F; Torres, R | 1 |
| Che, M; Coulter, CL; Gendelman, HE; Ghorpade, A; Hahn, F; Persidsky, Y; Reinhard, J; Rubocki, R; Swindells, S; Thylin, M; Zheng, J | 1 |
| Kawata, S; Okumoto, K; Saito, T; Shinzawa, H; Sugahara, K; Togashi, H; Watanabe, H | 1 |
2 trial(s) available for lamivudine and Atrophy
| Article | Year |
|---|---|
Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Atrophy; CD4 Lymphocyte Count; DNA, Mitochondrial; Drug Combinations; Drug Therapy, Combination; HIV Seropositivity; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Subcutaneous Fat; Treatment Outcome; Young Adult; Zidovudine | 2012 |
Switching to lopinavir/ritonavir with or without abacavir/lamivudine in lipoatrophic patients treated with zidovudine/abacavir/lamivudine.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Antiretroviral Therapy, Highly Active; Atrophy; Body Composition; Chemistry, Pharmaceutical; Dideoxynucleosides; Female; HIV Infections; HIV Protease Inhibitors; Humans; Intention to Treat Analysis; Lamivudine; Lipids; Lipodystrophy; Lopinavir; Male; Middle Aged; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Failure | 2013 |
3 other study(ies) available for lamivudine and Atrophy
| Article | Year |
|---|---|
Testicular histomorphologic and stereological alterations following short-term treatment with highly active antiretroviral drugs (HAART) in an experimental animal model.
Topics: alpha-Tocopherol; Animals; Anti-HIV Agents; Antioxidants; Antiretroviral Therapy, Highly Active; Ascorbic Acid; Atrophy; Lamivudine; Male; Models, Animal; Necrosis; Nevirapine; Random Allocation; Rats; Rats, Sprague-Dawley; Seminiferous Tubules; Stavudine | 2014 |
Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia.
Topics: Adult; AIDS Dementia Complex; Anti-HIV Agents; Atrophy; Brain; Female; Humans; Ibuprofen; Indinavir; Lamivudine; Magnetic Resonance Imaging; Neurons; Neurotoxins; Nitric Oxide; Quinolinic Acid; Toxicity Tests; Tumor Necrosis Factor-alpha; Zidovudine | 1998 |
Lamivudine and rapid regeneration of the atrophic liver in decompensated cirrhosis due to hepatitis B.
Topics: Atrophy; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Function Tests; Liver Regeneration; Male; Middle Aged; Reverse Transcriptase Inhibitors; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2002 |